Brief: Copley Acquisition Corp (NYSE Copl) And Ignite Proteomics Announce Business Combination Agreement To Advance Precision Oncology
11/06/2026 11:02
BRIEF-Copley Acquisition Corp (NYSE Copl) And Ignite Proteomics Announce Business Combination Agreement To Advance Precision Oncology June 11 (Reuters) - Copley Acquisition Corp COPL.N:
COPLEY ACQUISITION CORP (NYSE: COPL) AND IGNITE PROTEOMICS ANNOUNCE BUSINESS COMBINATION AGREEMENT TO ADVANCE PRECISION ONCOLOGY
COPLEY ACQUISITION - DEAL VALUES IGNITE PROTEOMICS AT $150 MILLION PRO FORMA ENTERPRISE VALUE
COPLEY ACQUISITION - IGNITE PROTEOMICS, TO BE LISTED ON NYSE ON DEAL CLOSE
Source text: ID:nGNXccpQHV
Further company coverage: COPL.N